These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21862633)

  • 1. Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B.
    Prenzel T; Begus-Nahrmann Y; Kramer F; Hennion M; Hsu C; Gorsler T; Hintermair C; Eick D; Kremmer E; Simons M; Beissbarth T; Johnsen SA
    Cancer Res; 2011 Sep; 71(17):5739-53. PubMed ID: 21862633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
    Powers GL; Ellison-Zelski SJ; Casa AJ; Lee AV; Alarid ET
    Oncogene; 2010 Mar; 29(10):1509-18. PubMed ID: 19946334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
    Fan M; Bigsby RM; Nephew KP
    Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone H2B monoubiquitination: roles to play in human malignancy.
    Cole AJ; Clifton-Bligh R; Marsh DJ
    Endocr Relat Cancer; 2015 Feb; 22(1):T19-33. PubMed ID: 24891457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
    Cooper C; Liu GY; Niu YL; Santos S; Murphy LC; Watson PH
    Clin Cancer Res; 2004 Dec; 10(24):8720-7. PubMed ID: 15623657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of estrogen receptor and p21(Waf1) in bortezomib-induced growth inhibition in human breast cancer cells.
    Maynadier M; Shi J; Vaillant O; Gary-Bobo M; Basile I; Gleizes M; Cathiard AM; Wah JL; Sheikh MS; Garcia M
    Mol Cancer Res; 2012 Nov; 10(11):1473-81. PubMed ID: 22964432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
    Zhang K; Wang J; Tong TR; Wu X; Nelson R; Yuan YC; Reno T; Liu Z; Yun X; Kim JY; Salgia R; Raz DJ
    Int J Cancer; 2017 Aug; 141(4):766-777. PubMed ID: 28481029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteasome inhibitor bortezomib induces an inhibitory chromatin environment at a distal enhancer of the estrogen receptor-α gene.
    Powers GL; Rajbhandari P; Solodin NM; Bickford B; Alarid ET
    PLoS One; 2013; 8(12):e81110. PubMed ID: 24339902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.
    Zhang X; Schulz R; Edmunds S; Krüger E; Markert E; Gaedcke J; Cormet-Boyaka E; Ghadimi M; Beissbarth T; Levine AJ; Moll UM; Dobbelstein M
    Mol Cell; 2015 Jul; 59(2):243-57. PubMed ID: 26145175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms.
    Bedi U; Scheel AH; Hennion M; Begus-Nahrmann Y; Rüschoff J; Johnsen SA
    Oncogene; 2015 Jan; 34(4):465-73. PubMed ID: 24441044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers.
    Segala G; Bennesch MA; Pandey DP; Hulo N; Picard D
    Mol Cell; 2016 Oct; 64(2):334-346. PubMed ID: 27692985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.
    Spolverini A; Fuchs G; Bublik DR; Oren M
    Oncogene; 2017 Oct; 36(42):5819-5828. PubMed ID: 28604753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.
    Dickson KA; Cole AJ; Gill AJ; Clarkson A; Gard GB; Chou A; Kennedy CJ; Henderson BR; ; Fereday S; Traficante N; Alsop K; Bowtell DD; deFazio A; Clifton-Bligh R; Marsh DJ
    Hum Mol Genet; 2016 Dec; 25(24):5460-5471. PubMed ID: 27798111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
    Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
    Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells.
    Schneider D; Chua RL; Molitor N; Hamdan FH; Rettenmeier EM; Prokakis E; Mishra VK; Kari V; Wegwitz F; Johnsen SA; Kosinsky RL
    Clin Epigenetics; 2019 Jul; 11(1):98. PubMed ID: 31266541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.
    Kinyamu HK; Collins JB; Grissom SF; Hebbar PB; Archer TK
    Mol Carcinog; 2008 Nov; 47(11):845-85. PubMed ID: 18381591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis.
    Wegwitz F; Prokakis E; Pejkovska A; Kosinsky RL; Glatzel M; Pantel K; Wikman H; Johnsen SA
    Cell Death Dis; 2020 Oct; 11(10):873. PubMed ID: 33070155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.